CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
House Dust Mite SLIT +2 morebiological
Likely dose
House Dust Mite SLIT 143 AU/ml daily (low dose) or 10,000 AU/ml daily (high dose)AI-extracted
Key inclusion· 1
  • ✓Diagnosis of house dust mite-induced allergic rhinitis with mild intermittent asthma
Key exclusion· 2
  • ✕Prior immunotherapy for house dust mite asthma
  • ✕Pregnancy or breastfeeding

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00200850
NCT00200850N/ACompleted
CompareCT.gov

Sublingual Immunotherapy in Dust Mite Allergy

University of Wisconsin, Madison·interventional·Posted Sep 20, 2005·Updated Jun 12, 2019

In Brief

A clinical study evaluating House Dust Mite SLIT, High dose SLIT, and 1 other intervention for Asthma. Completed, enrolled 31 participants across 1 site.

Detailed Summary

This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for patients with intermittent mild asthma caused by dust mites.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsNational Center for Complementary and Integrative Health (NCCIH)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 20, 2005
Enrollment StartJan 1, 2006
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 20.8 years ago

Interventions

House Dust Mite SLITbiological

low dose SLIT 143 Allergen Units(AU)/ml daily

High dose SLITbiological

House Dust Mite SLIT- 10,000 Allergen units(AU)/ml daily

Placebo SLITbiological

Placebo SLIT daily